Finance

Beta
Lists
AGL:NYSE
Agilon Health Inc
$96.85
+1.70%
(+1.62) 1D
$95.05
-1.86% (-1.80)
After hours
Closed: Jun 5, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGL...
Open
$94.56
High
$99.14
Low
$91.17
Mkt. cap
1.62B
Avg. vol.
497.81K
Volume
215.18K
52-wk high
$99.14
52-wk low
$7.48
EPS
-$21.41
Beta
3.02
Shares outstanding
16.68M
No. of employees
856
Open
$94.56
High
$99.14
Low
$91.17
Mkt. cap
1.62B
Avg. vol.
497.81K
Volume
215.18K
52-wk high
$99.14
52-wk low
$7.48
EPS
-$21.41
Beta
3.02
Shares outstanding
16.68M
No. of employees
856
Analyst outlook
Analyst Ratings
Based on 15 analysts giving stock ratings to AGL in the past 3 months
Hold
Buy
4
Hold
9
Sell
2
12 month forecast
Based on 15 Wall Street analysts offering 12 month price targets for AGL in the last 3 months.
Highest
Current $96.85
$95.00 (-1.91%)
Average
$57.15 (-40.99%)
Lowest
$21.00 (-78.32%)
News stories
From sources across the web
About Agilon Health Inc
CEOSteven Sell
Employees856
Founded2016
HeadquartersWesterville, Ohio, United States
SectorHealth care provider
Websiteagilonhealth.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$2.32 / $0.93
+150.00%beat
Revenue / Est. (USD)
1.42B / 1.38B
+2.71%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.39B
1.44B
1.57B
1.42B
Cost of goods sold
1.45B
1.50B
1.66B
1.36B
Cost of revenue
1.45B
1.50B
1.66B
1.36B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.16M
52.11M
58.76M
48.12M
Operating expense
63.48M
59.54M
65.73M
54.90M
Total operating expenses
1.51B
1.56B
1.73B
1.41B
Operating income
-115.91M
-127.18M
-156.40M
10.11M
Other non operating income
4.28M
5.64M
38.04M
13.22M
EBT including unusual items
-104.31M
-110.54M
-187.56M
29.94M
EBT excluding unusual items
-104.19M
-106.45M
-150.13M
36.06M
Income tax expense
62.00K
-331.00K
1.32M
28.00K
Effective tax rate
-0.06%
0.30%
-0.71%
0.09%
Other operating expenses
-
-
-
-
Net income
-104.37M
-110.21M
-188.88M
48.92M
Net profit margin
-7.48%
-7.68%
-12.03%
3.44%
Earnings per share
-6.30
-6.40
-8.95
2.32
Interest and investment income
3.60M
3.80M
3.00M
2.80M
Interest expense
-1.57M
-1.84M
-1.72M
-1.81M
Net interest expenses
2.03M
1.96M
1.28M
989.00K
Depreciation and amortization charges
7.32M
7.43M
6.97M
6.79M
EBITDA
-108.59M
-119.75M
-152.68M
16.90M
Gain or loss from assets sale
-
-
-14.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer